Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
26
|
| pubmed:dateCreated |
1997-11-10
|
| pubmed:abstractText |
REFERENCE DATA FOR THE THERAPEUTIC MANAGEMENT OF GASTROESOPHAGEAL REFLUX (GOR): The natural history of the disease; the short- and long-term efficiency of the various therapies and their potential risks; patient-related factors (age, associated disorders, personal preference, duration and severity of his reflux disease). First line therapy will be medical in all cases. POTENTIAL CANDIDATES FOR SURGERY: Only patients with proven GOR, with or without esophagitis but who have required proton-pump inhibitors (PPI) are potential candidates for surgery; if their esophagitis is not healed after a 8-week PPI regimen, especially, if they remain symptomatic; if they relapse shortly after treatment withdrawal and require either frequent intermittent courses or long-term continuous treatment with PPI; moreover if they relapse while continuously taking PPI at usual dosage. LONG-TERM TREATMENT WITH PPI: It looks safe. However there still is some concern about the complete safety of extremely prolonged treatments started in young patients.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0755-4982
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
13
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1257-63
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1997
|
| pubmed:articleTitle |
[Gastroesophageal reflux (II). Major medical therapeutics: efficacy and risks].
|
| pubmed:affiliation |
Service de Gastroentérologie, Hôpital Louis Mourier, Colombes.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Review
|